283 research outputs found
A 1.4 deg^2 blind survey for C II], C III] and C IV at z ~ 0.7-1.5 - I. Nature, morphologies and equivalent widths
A 1.4 deg^2 blind survey for C II], C III] and C IV at z ~ 0.7-1.5 - II. Luminosity functions and cosmic average line ratios
Article / Letter to editorSterrewach
World Workshop on Oral Medicine VII : Relative frequency of oral mucosal lesions in children, a scoping review
Objective: To detail a scoping review on the global and regional relative frequencies of oral mucosal disorders in the children based on both clinical studies and those reported from biopsy records. Materials and Methods: A literature search was completed from 1 January 1990 to 31 December 2018 using PubMed and EMBASE. Results: Twenty clinical studies (sample size: 85,976) and 34 studies from biopsy services (40,522 biopsies) were included. Clinically, the most frequent conditions were aphthous ulcerations (1.82%), trauma-associated lesions (1.33%) and herpes simplex virus (HSV)-associated lesions (1.33%). Overall, the most commonly biopsied lesions were mucoceles (17.12%), fibrous lesions (9.06%) and pyogenic granuloma (4.87%). By WHO geographic region, the pooled relative frequencies of the most common oral lesions were similar between regions in both clinical and biopsy studies. Across regions, geographic tongue (migratory glossitis), HSV lesions, fissured tongue and trauma-associated ulcers were the most commonly reported paediatric oral mucosal lesions in clinical studies, while mucoceles, fibrous lesions and pyogenic granuloma were the most commonly biopsied lesions. Conclusions: The scoping review suggests data from the clinical studies and biopsy records shared similarities in the most commonly observed mucosal lesions in children across regions. In addition, the majority of lesions were benign in nature
Analysis of linear long-term trend of aerosol optical thickness derived from SeaWiFS using BAER over Europe and South China
The main purposes of the present paper are not only to investigate linear long-term trends of Aerosol Optical Thickness (AOT) at 443 and 555 nm over regions in Europe and South China, but also to show the uncertainty caused by cloud disturbance in the trend analysis of cloud-free aerosol. These research areas are the densely urbanised and often highly polluted regions. The study uses the Bremen AErosol Retrieval (BAER) and Sea-viewing Wide Field-of-view Sensor (SeaWiFS) data for AOT retrievals in the specified regions from October 1997 to May 2008. In order to validate the individually retrieved AOTs and the corresponding trends, AErosol RObotic NETwork (AERONET) level 2.0 data have been used. The retrieved AOTs were in good agreement with those of AERONET (0.79 ≤ <i>R</i> ≤ 0.88, 0.08 ≤ RMSD ≤ 0.13). The contamination of the aerosol retrievals and/or AERONET observations by thin clouds can significantly degrade the AOT and lead to statistically non-representative monthly-means, especially during cloudy seasons. Therefore an inter-correction method has been developed and applied. The "corrected" trends for both BAER SeaWiFS and AERONET AOT were similar and showed in average a relative difference of &sim;25.19%. In general terms, negative trends (decrease of aerosol loading) were mainly observed over European regions, with magnitudes up to −0.00453 and −0.00484 yr<sup>−1</sup> at 443 and 555 nm, respectively. In contrast, the trend in Pearl River Delta was positive, most likely attributed to rapid urbanization and industrialization. The magnitudes of AOT increased by +0.00761 and +0.00625 yr<sup>−1</sup> respectively at 443 and 555 nm
A 1.4 deg^2 blind survey for C II], C III] and C IV at z ~ 0.7-1.5 - II. Luminosity functions and cosmic average line ratios
Galaxie
Inclusion Complex Of S(-) Bupivacaine And 2-hydroxypropyl- β-cyclodextrin: Study Of Morphology And Cytotoxicity
Local anesthetics (LA) belong to a class of pharmacological compounds that attenuate or eliminate pain by binding to the sodium channel of excitable membranes, blocking the influx of sodium ions and the propagation of the nerve impulse. S (-) bupivacaine (S(-) bvc) is a local anesthetic of amino-amide type, widely used in surgery and obstetrics for sustained peripheral and central nerve blockade. This article focuses on the characterization of an inclusion complex of S(-) bvc in 2-hydroxypropyl-β-cyclodextrin (HP-β-CD). Differential scanning calorimetry, scanning electron microscopy and X-Ray diffraction analysis showed structural changes in the complex. In preliminary toxicity studies, the cell viability tests revealed that the inclusion complex decreased the toxic effect (p<0.001) produced by S(-) bvc. These results suggest that the S(-) bvc:HP-β-CD inclusion complex represents a promising agent for the treatment of regional pain.273207212Araújo, D.R., Cereda, C.M., Brunetto, G.B., Pinto, L.M.A., Santana, M.H., de Paula, E., Encapsulation of mepivacaine prolongs the analgesia provided by sciatic nerve blockade in mice (2004) Can J Anaesth, 51, pp. 566-572Araújo, D.R., Fraceto, L.F., Braga, A.F.A., de Paula, E., Drug-delivery systems for racemic bupivacaine (S50-R50) and bupivacaine enantiomeric mixture (S75-R25):cyclodextrins complexation effects on sciatic nerve blockade in mice (2005) Rev Bras Anestesiol, 55, pp. 316-328Araújo, D.R., Moraes, C.M., Fraceto, L.F., Braga, A.F.A., de Paula, E., Cyclodextrin-bupivacaine enantiomeric mixture (S75-R25) inclusion complex and intrathecal anesthesia in rats (2006) Rev Bras Anestesiol, 56, pp. 495-506Bibby, D., Davies, N.M., Tueker, I.G., Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems (2000) Int J Pharm, 197, pp. 1-11Covino, B.G., Vassalo, H.G., (1976) Local anesthetics: Mechanisms of action and clinical use, , New York: Grune and Stratton;, 255pFoster, R.H., Markham, A., Levobupivacaine. A review of its pharmacology and use as a local anaesthetic (2000) Drugs, 59, pp. 551-579Grant, G.J., Bansinath, M., Liposomal delivery systems for local anesthetics (2001) Reg Anesth Pain Med, 26, pp. 61-63Gristwood, R.W., Cardiac and CNS toxicity of levobupivacaine: Strengths of evidence for advantage over bupivacaine (2002) Drug Saf, 25, pp. 153-163Hirayama, F., Uekama, K., Cyclodextrin-based controlled drug release system (1999) Adv Drug Deliv Rev, 36, pp. 125-141Huang, Y.F., Pryor, M.E., Mather, L.E., Veering, B.T., Cardiovascular and central nervous system effects of intravenous S-bupivacaine and bupivacaine in sheep (1998) Anesth Analg, 86, pp. 797-804Jong, R.H., (1994) Local anesthetics, , Springfield: CC. Thomas;, 325pKohata, S., Jyodi, K., Ohyoshi, A., Thermal decomposition of cyclodextrins (α -, β-, γ, and modified β-CyD) and of metal-(β-CyD) complex in the solid phase (1993) Thermochim Acta, 217, pp. 187-198Loftsson, T., Brewster, M.E., Pharmaceutical application of Cyclodextrin. 1. Drug solubilization and stabilization (1996) J Pharm Sci, 85, pp. 1017-1025Loukas, Y.L., Vraka, V., Gregoriadis, G., Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives (1997) J Pharm Biomed Anal, 16, pp. 263-268Mather, L.E., McCall, P., McNicol, P.L., Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplant patients (1995) Anesth Analg, 80, pp. 328-335Michaud, M., Icart, S., Determination of the substitution of hydroxypropylbetadex using fourier transform infrared spectrophotometry (2001) PharmEuropa, 13, pp. 714-716Naidu, N.B., Chowdary, K.P.R., Murthy, K.V.R., Satyanarayana, V., Hayman, A.R., Becket, G., Physicochemical characterization and dissolution properties of meloxicam-cyclodextrin binary systems (2004) J Pharm Biomed Anal, 35, pp. 75-86Pinto, L.M.A., Fraceto, L.F., Santana, M.H.A., Pertinhez, T.A., Oyama, S., de Paula, E., Physico-chemical characterization of benzocaine-β-cyclodextrin inclusion complexes (2005) J Pharm Biomed Anal, 39, pp. 956-963Ren, X., Xue, Y., Liu, J., Zhang, K., Zheng, J., Lou, G., Gou, C., Shen, J., A novel cyclodextrin-deri ved tellurium compound with glutathione peroxidase (2002) Chembiochem, 3, pp. 363-365Rose, J.S., Neal, J.M., Kopacz, D.J., Extended-duration analgesia: Update on microspheres and liposomes (2005) Reg Anesth Pain Med, 30, pp. 275-285Strichartz, G.R., Ritchie, J.M., (1987) Local anesthetics: Handbook of experimental pharmacology, , Berlin: Springer-Verlag;, 445pThompson, D.O., Cyclodextrin-enabling excipients: Their present and future use in pharmaceuticals (1997) Crit Rev Ther Drug Carrier Syst, 14, pp. 1-10
Addressing the Challenges of Situationally-Induced Impairments and Disabilities in Mobile Interaction
Situationally-induced impairments and disabilities (SIIDs) make it difficult for users of interactive computing systems to perform tasks due to context (e.g., listening to a phone call when in a noisy crowd) rather than a result of a congenital or acquired impairment (e.g., hearing damage). SIIDs are a great concern when considering the ubiquitousness of technology in a wide range of contexts. Considering our daily reliance on technology, and mobile technology in particular, it is increasingly important that we fully understand and model how SIIDs occur. Similarly, we must identify appropriate methods for sensing and adapting technology to reduce the effects of SIIDs. In this workshop, we will bring together researchers working on understanding, sensing, modelling, and adapting technologies to ameliorate the effects of SIIDs. This workshop will provide a venue to identify existing research gaps, new directions for future research, and opportunities for future collaboration
Evidence for PopIII-like Stellar Populations in the Most Luminous Lyman-α Emitters at the Epoch of Reionization: Spectroscopic Confirmation
Galaxie
- …